Work

Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics

Year: 2024

Type: article

Abstract: Children with severe asthma have increased risk of severe exacerbations and reduced lung function.1 In clinical practice, providers will manage patients across a range of baseline demographics and disease features, which are associated with asthma disease severity2 and can affect drug treatment outcomes.3

Source: The Journal of Allergy and Clinical Immunology In Practice

DOI: 10.1016/j.jaip.2024.08.010

Authors: Jorge F. Maspero, Alessandro G. Fiocchi, Antoine Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, David J. Lederer, Bolanle Akinlade, Megan Hardin

Institutions: Bambino Gesù Children's Hospital, Université de Lille, Centre Hospitalier Universitaire de Lille, Hôpital Jeanne de Flandre, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Sanofi (United States), Regeneron (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,000

Funders: Sanofi, Regeneron Pharmaceuticals

OpenAlex ID: W4401423314

FWCI: 0.472

Cites: 8

Cited by: 2

Related to: 10